Share on LinkedInShare on LinkedIn

ARTICLE · 02 DECEMBER 2024

Inventive Step Approach Confirmed In NanoString Revocation Decision

The UPC's Central Division revoked Harvard's EP 2 794 928 B1 patent, citing lack of novelty and inventive step. It confirmed jurisdiction despite parallel German proceedings, emphasizing procedural efficiency and rejecting late-stage amendments.

United KingdomIntellectual Property

The Central Division (Munich) has handed down a significant revocation decision in the ongoing patent battle between NanoString v 10x Genomics and President and Fellows of Harvard College. This follows the Court of Appeal's decision earlier in the year in relation to another (closely related) patent, in which it set aside a preliminary injunction ordered by the Munich Local Division, holding that the patent was (more likely than not) invalid - see summary here.

By way of brief background, the patent EP 2 794 928 B1 (the "Patent"), owned by President and Fellows of Harvard College, concerns spatial profiling technology, adopting an in situ method for detecting RNA. NanoString brought these proceedings before the Central Division, challenging the validity of the Patent and seeking for it to be revoked in its entirety.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from